The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.

Danuglipron: According to the company's latest statement, one patient experienced a potential liver injury that may have been ...

U.S. pharmaceutical giant Pfizer (PFE) has ended development of its experimental weight loss pill after a patient experienced ...

A new study has found that most COVID-19 treatments approved in the United States are safe and not linked to serious side ...

Everyone in the study began taking their pills once a day within three days of when their housemate first reported symptoms ...

Researchers at Rutgers University have created a new antiviral drug for COVID-19 that could be safer and more effective than Paxlovid, the current leading treatment. The new drug, called Jun13296, may ...

The FDA stressed the treatment should complement rather than replace vaccines, which remain the frontline tool against the coronavirus. But pills that are available at pharmacies should be much ...

AstraZenca is testing a once-daily PCSK9 inhibitor, currently known as AZD0780. After 12 weeks of use alongside standard ...